Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    "Neonatal herpes"
Show Display Options
Rank Status Study
1 Not yet recruiting A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)
Condition: Herpes Simplex Virus
Interventions: Drug: Novel Antiviral Drug;   Drug: Placebo
2 Completed Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection
Condition: Herpes Simplex
Intervention: Drug: acyclovir
3 Completed Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth
Condition: Herpes Simplex
Intervention: Drug: acyclovir
4 Completed
Has Results
Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
Condition: Herpes Simplex
Interventions: Drug: Acyclovir;   Drug: Placebo
5 Completed
Has Results
Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
Condition: Herpes Simplex
Interventions: Drug: Acyclovir;   Drug: Placebo

Indicates status has not been verified in more than two years